This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07287/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07287/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07287/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07287/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07287/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07287
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB07287 n14:DB07287
dcterms:title
2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL
adms:identifier
n7:DB07287 n8:8PC n9:17347434 n12:16220130 n13:99443758
n3:IUPAC-Name
n4:271B5C84-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5C8A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5C89-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5C86-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5C87-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5C88-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5C82-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5C80-363D-11E5-9242-09173F13E4C5 n4:271B5C83-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5C81-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5C90-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5C91-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5C8B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5C8C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5C8E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5C8D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5C8F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5C96-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5C98-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5C99-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5C95-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5C94-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5C97-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5C85-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5C92-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5C93-363D-11E5-9242-09173F13E4C5